
亚太地区糖尿病护理设备市场预测至 2028 年 – COVID-19 影响和区域分析 – 按类型(血糖监测设备和胰岛素输送设备)和最终用户(家庭护理以及医院和诊所)
No. of Pages: 157 | Report Code: TIPRE00005736 | Category: Life Sciences
No. of Pages: 157 | Report Code: TIPRE00005736 | Category: Life Sciences
亚太地区糖尿病护理设备市场预计将从2022年的63.5097亿美元增长到2028年的95.549亿美元;预计 2022 年至 2028 年复合年增长率为 5.2%。
医疗保健行业的技术进步正在鼓励市场参与者关注胰岛素输送装置的研究和开发。将胰岛素输送到人体的方法有很多种,包括针头、胰岛素笔和胰岛素泵。胰岛素泵是一种小型计算机化糖尿病管理设备,与皮下插管相连,可缓慢且连续地输送胰岛素水平。最佳的糖尿病管理取决于准确的血糖监测设备。血糖监测设备的技术进步减少了对血液样本的需求,同时提高了准确性。此外,血糖仪和胰岛素输送设备之间传输数据的能力也得到了提高。智能胰岛素笔是一种可重复使用的注射笔,带有易于使用的智能手机应用程序,可以帮助糖尿病患者管理胰岛素输送。这种智能设备可以计算和跟踪剂量,同时还为患者提供有用的提醒。 2020年11月,美敦力公司推出了InPen,它与实时Guardian Connect CGM数据相关。对胰岛素笔的持续研究支持了预测期内糖尿病护理设备市场的增长。笔式针头和注射器是向糖尿病患者注射胰岛素最常用的装置。各个制造商正在开发创新产品,以维持高度分散的针市场。此外,监管审批的便捷性导致中型企业进入市场并与本地和老牌企业竞争。开发具有精确润滑功能以减轻疼痛感的笔用针头一直是制造商研究的另一个重点。因此,技术进步和新产品不断涌入市场预计将在预测几年内推动市场的增长。
凭借新功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动亚太地区糖尿病护理设备市场的发展。亚太地区糖尿病护理设备市场预计在预测期内将以良好的复合年增长率增长。
亚太地区糖尿病护理设备市场收入和预测至 2028 年(美国)百万美元)
亚太地区糖尿病护理设备市场细分
亚太地区糖尿病护理设备市场根据类型、最终用户和国家/地区进行细分。根据类型,市场分为血糖监测设备和胰岛素输送设备。血糖监测设备细分市场将在 2022 年占据市场主导地位。血糖监测设备细分市场进一步分为试纸、血糖仪、采血针等。同样,胰岛素输送设备细分为胰岛素笔、胰岛素注射器、胰岛素泵等。根据最终用户,亚太地区糖尿病护理设备市场分为家庭护理和医院护理设备。诊所。到 2022 年,家庭护理细分市场将占据市场主导地位。根据国家/地区,亚太地区糖尿病护理设备市场分为中国、印度、日本、韩国、澳大利亚和亚太地区其他地区。中国将在 2022 年占据市场主导地位。
B.布劳恩·梅尔松根股份公司; BD;德克斯康公司;礼来公司。; F.霍夫曼-拉罗氏有限公司;英苏莱特公司;美敦力;诺和诺德公司; Tandem 糖尿病护理公司;和 Terumo Corporation 是亚太地区糖尿病护理设备市场的领先公司之一。
Strategic insights for Asia Pacific Diabetes Care Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 6,350.97 Million |
Market Size by 2028 | US$ 9,554.90 Million |
Global CAGR (2022 - 2028) | 5.2% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Diabetes Care Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Diabetes Care Devices Market is valued at US$ 6,350.97 Million in 2022, it is projected to reach US$ 9,554.90 Million by 2028.
As per our report Asia Pacific Diabetes Care Devices Market, the market size is valued at US$ 6,350.97 Million in 2022, projecting it to reach US$ 9,554.90 Million by 2028. This translates to a CAGR of approximately 5.2% during the forecast period.
The Asia Pacific Diabetes Care Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Diabetes Care Devices Market report:
The Asia Pacific Diabetes Care Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Diabetes Care Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Diabetes Care Devices Market value chain can benefit from the information contained in a comprehensive market report.